BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 30135508)

  • 1. HPV E4 expression and DNA hypermethylation of CADM1, MAL, and miR124-2 genes in cervical cancer and precursor lesions.
    Zummeren MV; Kremer WW; Leeman A; Bleeker MCG; Jenkins D; Sandt MV; Doorbar J; Heideman DAM; Steenbergen RDM; Snijders PJF; Kenter GG; Quint WGV; Berkhof J; Meijer CJLM
    Mod Pathol; 2018 Dec; 31(12):1842-1850. PubMed ID: 30135508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Classification of high-grade cervical intraepithelial neoplasia by p16
    Vink FJ; Dick S; Heideman DAM; De Strooper LMA; Steenbergen RDM; Lissenberg-Witte BI; ; Floore A; Bonde JH; Oštrbenk Valenčak A; Poljak M; Petry KU; Hillemanns P; van Trommel NE; Berkhof J; Bleeker MCG; Meijer CJLM
    Int J Cancer; 2021 Aug; 149(3):707-716. PubMed ID: 33729551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of cervical biopsies of women with HIV and HPV co-infection using p16
    Kremer WW; Vink FJ; van Zummeren M; Dreyer G; Rozendaal L; Doorbar J; Bleeker MCG; Meijer CJLM
    Mod Pathol; 2020 Oct; 33(10):1968-1978. PubMed ID: 32249820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FAM19A4/miR124-2 Methylation Testing and Human Papillomavirus (HPV) 16/18 Genotyping in HPV-Positive Women Under the Age of 30 Years.
    Vink FJ; Meijer CJLM; Hesselink AT; Floore AN; Lissenberg-Witte BI; Bonde JH; Pedersen H; Cuschieri K; Bhatia R; Poljak M; Oštrbenk Valenčak A; Hillemanns P; Quint WGV; Del Pino M; Kenter GG; Steenbergen RDM; Heideman DAM; Bleeker MCG
    Clin Infect Dis; 2023 Feb; 76(3):e827-e834. PubMed ID: 35686306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of p16 and HPV E4 on biopsy samples and methylation of FAM19A4 and miR124-2 on cervical cytology samples in the classification of cervical squamous intraepithelial lesions.
    Leeman A; Jenkins D; Del Pino M; Ordi J; Torné A; Doorbar J; Meijer CJLM; van Kemenade FJ; Quint WGV
    Cancer Med; 2020 Apr; 9(7):2454-2461. PubMed ID: 32022461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CADM1, MAL, and miR124 Promoter Methylation as Biomarkers of Transforming Cervical Intrapithelial Lesions.
    Del Pino M; Sierra A; Marimon L; Martí Delgado C; Rodriguez-Trujillo A; Barnadas E; Saco A; Torné A; Ordi J
    Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31067838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CADM1 and MAL methylation status in cervical scrapes is representative of the most severe underlying lesion in women with multiple cervical biopsies.
    van Baars R; van der Marel J; Snijders PJ; Rodriquez-Manfredi A; ter Harmsel B; van den Munckhof HA; Ordi J; del Pino M; van de Sandt MM; Wentzensen N; Meijer CJ; Quint WG
    Int J Cancer; 2016 Jan; 138(2):463-71. PubMed ID: 26219541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylation of Cervical Neoplastic Cells Infected With Human Papillomavirus 16.
    Ki EY; Lee KH; Hur SY; Rhee JE; Kee MK; Kang C; Park JS
    Int J Gynecol Cancer; 2016 Jan; 26(1):176-83. PubMed ID: 26552048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of
    Holubekova V; Mersakova S; Grendar M; Snahnicanova Z; Kudela E; Kalman M; Lasabova Z; Danko J; Zubor P
    Genet Test Mol Biomarkers; 2020 May; 24(5):256-263. PubMed ID: 32311274
    [No Abstract]   [Full Text] [Related]  

  • 10. Investigating Diagnostic Problems of CIN1 and CIN2 Associated With High-risk HPV by Combining the Novel Molecular Biomarker PanHPVE4 With P16INK4a.
    van Baars R; Griffin H; Wu Z; Soneji YJ; van de Sandt M; Arora R; van der Marel J; Ter Harmsel B; Jach R; Okon K; Huras H; Jenkins D; Quint W; Doorbar J
    Am J Surg Pathol; 2015 Nov; 39(11):1518-1528. PubMed ID: 26379150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Follow-up of high-risk HPV positive women by combined cytology and bi-marker CADM1/MAL methylation analysis on cervical scrapes.
    Verhoef VM; van Kemenade FJ; Rozendaal L; Heideman DA; Bosgraaf RP; Hesselink AT; Melchers WJ; Massuger LF; Bekkers RL; Steenbergen RD; Berkhof J; Snijders PJ; Meijer CJ
    Gynecol Oncol; 2015 Apr; 137(1):55-9. PubMed ID: 25667975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CADM1, MAL and miR124-2 methylation analysis in cervical scrapes to detect cervical and endometrial cancer.
    De Strooper LM; van Zummeren M; Steenbergen RD; Bleeker MC; Hesselink AT; Wisman GB; Snijders PJ; Heideman DA; Meijer CJ
    J Clin Pathol; 2014 Dec; 67(12):1067-71. PubMed ID: 25281766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stratification of HPV-induced cervical pathology using the virally encoded molecular marker E4 in combination with p16 or MCM.
    Griffin H; Soneji Y; Van Baars R; Arora R; Jenkins D; van de Sandt M; Wu Z; Quint W; Jach R; Okon K; Huras H; Singer A; Doorbar J
    Mod Pathol; 2015 Jul; 28(7):977-93. PubMed ID: 25953390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromosomal signatures of a subset of high-grade premalignant cervical lesions closely resemble invasive carcinomas.
    Wilting SM; Steenbergen RD; Tijssen M; van Wieringen WN; Helmerhorst TJ; van Kemenade FJ; Bleeker MC; van de Wiel MA; Carvalho B; Meijer GA; Ylstra B; Meijer CJ; Snijders PJ
    Cancer Res; 2009 Jan; 69(2):647-55. PubMed ID: 19147580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defining hrHPV genotypes in cervical intraepithelial neoplasia by laser capture microdissection supports reflex triage of self-samples using HPV16/18 and FAM19A4/miR124-2 methylation.
    Leeman A; Ebisch RMF; Kasius A; Bosgraaf RP; Jenkins D; van de Sandt MM; de Strooper LMA; Heideman DAM; Snijders PJF; Massuger LFAG; Bekkers RLM; Meijer CJLM; van Kemenade FJ; Quint WGV; Melchers WJG
    Gynecol Oncol; 2018 Nov; 151(2):311-318. PubMed ID: 30219239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CADM1 and MAL promoter methylation levels in hrHPV-positive cervical scrapes increase proportional to degree and duration of underlying cervical disease.
    Bierkens M; Hesselink AT; Meijer CJ; Heideman DA; Wisman GB; van der Zee AG; Snijders PJ; Steenbergen RD
    Int J Cancer; 2013 Sep; 133(6):1293-9. PubMed ID: 23456988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three-tiered score for Ki-67 and p16
    van Zummeren M; Leeman A; Kremer WW; Bleeker MCG; Jenkins D; van de Sandt M; Heideman DAM; Steenbergen R; Snijders PJF; Quint WGV; Berkhof J; Meijer CJLM
    J Clin Pathol; 2018 Nov; 71(11):981-988. PubMed ID: 30012698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant promoter methylation can be useful as a marker of recurrent disease in patients with cervical intraepithelial neoplasia grade III.
    Terra AP; Murta EF; Maluf PJ; Caballero OL; Brait M; Adad SJ
    Tumori; 2007; 93(6):572-9. PubMed ID: 18338492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylation of the hsa-miR-124, SOX1, TERT, and LMX1A genes as biomarkers for precursor lesions in cervical cancer.
    Rogeri CD; Silveira HCS; Causin RL; Villa LL; Stein MD; de Carvalho AC; Arantes LMRB; Scapulatempo-Neto C; Possati-Resende JC; Antoniazzi M; Longatto-Filho A; Fregnani JHTG
    Gynecol Oncol; 2018 Sep; 150(3):545-551. PubMed ID: 29960712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p16INK4A immunohistochemical staining and predictive value for progression of cervical intraepithelial neoplasia grade 1: a prospective study in China.
    Liao GD; Sellors JW; Sun HK; Zhang X; Bao YP; Jeronimo J; Chen W; Zhao FH; Song Y; Cao Z; Zhang SK; Xi MR; Qiao YL
    Int J Cancer; 2014 Apr; 134(7):1715-24. PubMed ID: 24105727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.